The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number 34374. We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting our study. KTT is supported by the Vietnam International Education Cooperation Department. Access to PCCIU data was provided by Queen's University Belfast and the Centre for Academic Primary Care, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM.Peer reviewedPostprin
Breast and colorectal cancer are two of the most commonly diagnosed cancers in Ireland and worldwide...
IntroductionStudies have suggested that statins may inhibit tumor cell growth and possibly prevent c...
BACKGROUND: Numerous clinical trials have considered the potential linkages between statins and canc...
The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number...
Statins are among the most commonly prescribed drugs used to manage dyslipidemia. Hepatocellular car...
Statins are among the most commonly prescribed drugs used to manage dyslipidemia. Hepatocellular car...
The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number...
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are medications widely prescrib...
The objective of this study was to explore the association between statins use and risk of developin...
BACKGROUND & AIMS: Statins are widely used to treat hypercholesterolemia. Statins may prevent hepato...
Background: In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause ...
Statins are reported to reduce the risk of cancer, but the results of various published studies have...
In subjects with chronic hepatitis B (CHB), the lifetime risk of developing hepatocellular carcinoma...
Laboratory studies have suggested oncogenic roles of lipids, as well as anticarcinogenic effects of ...
We aimed to examine whether statin users have a lower risk of hepatocellular carcinoma (HCC) after c...
Breast and colorectal cancer are two of the most commonly diagnosed cancers in Ireland and worldwide...
IntroductionStudies have suggested that statins may inhibit tumor cell growth and possibly prevent c...
BACKGROUND: Numerous clinical trials have considered the potential linkages between statins and canc...
The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number...
Statins are among the most commonly prescribed drugs used to manage dyslipidemia. Hepatocellular car...
Statins are among the most commonly prescribed drugs used to manage dyslipidemia. Hepatocellular car...
The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number...
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are medications widely prescrib...
The objective of this study was to explore the association between statins use and risk of developin...
BACKGROUND & AIMS: Statins are widely used to treat hypercholesterolemia. Statins may prevent hepato...
Background: In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause ...
Statins are reported to reduce the risk of cancer, but the results of various published studies have...
In subjects with chronic hepatitis B (CHB), the lifetime risk of developing hepatocellular carcinoma...
Laboratory studies have suggested oncogenic roles of lipids, as well as anticarcinogenic effects of ...
We aimed to examine whether statin users have a lower risk of hepatocellular carcinoma (HCC) after c...
Breast and colorectal cancer are two of the most commonly diagnosed cancers in Ireland and worldwide...
IntroductionStudies have suggested that statins may inhibit tumor cell growth and possibly prevent c...
BACKGROUND: Numerous clinical trials have considered the potential linkages between statins and canc...